Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 2,200 shares, a decrease of 99.3% from the April 30th total of 300,900 shares. Based on an average trading volume of 1,381,600 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.
Vivos Price Performance
Shares of OTCMKTS RDGL traded down $0.00 during mid-day trading on Friday, reaching $0.13. The company's stock had a trading volume of 533,734 shares, compared to its average volume of 934,309. The firm has a market capitalization of $59.23 million, a PE ratio of -13.06 and a beta of 1.10. The stock has a fifty day moving average of $0.12 and a two-hundred day moving average of $0.12. Vivos has a 52 week low of $0.06 and a 52 week high of $0.26.
Vivos Company Profile
(
Get Free Report)
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Recommended Stories
Before you consider Vivos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivos wasn't on the list.
While Vivos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.